Concepedia

Alison Pilgrim

AP

Statistics

Publications

17

Citations

1.8K

H-Index

15

Active since

1983

Affiliations

Duke University(Current)

Humacyte (United States)

Yale University

Leiden University

Medical University of Lublin

Alison Pilgrim is an author at Duke University specializing in pharmacotherapy, headache disorders, and headache management.

Publications per year

1983–2022

17

Publications

17

Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials

Jeffrey H. Lawson, Marc H. Glickman, Marek Iłżecki et al. · The Lancet · 2016 · 364 citations

Medicine, Bioengineering, Nephrology +17

Subcutaneous sumatriptan during the migraine aura

D. Bates, Elizabeth Ashford, Rachel Dawson et al. · Neurology · 1994 · 195 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study

Hans‐Christoph Diener, Gilles Géraud, Miguel J. A. Láinez et al. · The Lancet Neurology · 2012 · 187 citations

Medicine, Pharmacology, Pharmacotherapy +10

Acute treatment of migraine with the selective 5-HT <sub>1F</sub> receptor agonist lasmiditan – A randomised proof-of-concept trial

Michel D. Ferrari, Uwe Reuter, Alison Pilgrim et al. · Cephalalgia · 2010 · 167 citations

Medicine, Pharmacology, Pharmacotherapy +17

Comparative Safety and Tolerability of Clopidogrel and Aspirin

L A Harker, Jean-Pierre Boissel, Alison Pilgrim et al. · Drug Safety · 1999 · 158 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

1–5 of 17